""

William Von Mueffling's Cantillon Capital Management has released its Q4 2025 portfolio update, providing insight into the investment strategies of the prominent hedge fund. As of December 2025, Cantillon Capital Management managed approximately $14 billion in assets. The portfolio update reveals significant holdings in major tech companies, including Microsoft and Alphabet, as well as substantial investments in the healthcare sector, particularly in pharmaceutical companies such as Johnson & Johnson and Pfizer. Founded in 2003 by William Von Mueffling, Cantillon Capital Management is a global long-short equity hedge fund based in New York. The fund's investment approach focuses on fundamental research and a disciplined, risk-aware strategy. With a strong track record of performance, Cantillon Capital Management continues to attract attention from investors and industry observers. The Q4 2025 update offers a glimpse into the fund's strategic decisions and sector allocations, highlighting its adaptability and commitment to delivering returns in a rapidly evolving market landscape.